Acute myeloid leukaemia (in remission) Withdrawn Phase 1 Trials for Fludarabine (DB01073)

Also known as: Acute Myeloid Leukemia in Remission / Acute myeloid leukemia (in remission) / Acute myeloblastic leukemia, in remission / Acute myeloid leukaemia in remission

IndicationStatusPhase
DBCOND0006975 (Acute myeloid leukaemia (in remission))Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02528877Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With MyelofibrosisSupportive Care